+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Services Market by Service Type, Technology, End User, Therapeutic Area, Molecule Type, Business Model - Global Forecast to 2030- Product Image
Drug Discovery Services Market by Service Type, Technology, End User, Therapeutic Area, Molecule Type, Business Model - Global Forecast to 2030- Product Image
Sale

Drug Discovery Services Market by Service Type, Technology, End User, Therapeutic Area, Molecule Type, Business Model - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146254
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug discovery services market is undergoing rapid evolution, shaped by advancing technologies, stricter regulatory requirements, and changing priorities among leading pharmaceutical and biotech organizations. As stakeholders seek new strategies to accelerate research and optimize costs, selecting the right service providers and innovative solutions has become central to driving competitive advantage.

Market Snapshot: Drug Discovery Services Market Growth

The Drug Discovery Services Market grew from USD 24.79 billion in 2024 to USD 28.49 billion in 2025. It is expected to continue growing at a CAGR of 14.48%, reaching USD 55.84 billion by 2030. This robust expansion highlights rising demand for outsourced R&D expertise, scalable testing platforms, and end-to-end solutions that span the full discovery pipeline. Larger biopharma firms and emerging biotech entrants alike are leveraging these services to streamline workflows and bring novel therapies to market more efficiently. As the market expands, new entrants, established players, and contract research organizations are actively shaping the ecosystem.

Scope & Segmentation

This report provides a comprehensive analysis of the drug discovery services market across multiple strategic dimensions:

  • Service Types: ADME DMPK testing, biomarker discovery, compound synthesis & scale-up, hit screening, lead optimization, target identification, and toxicity testing.
  • Technologies: Computational biology (including bioinformatics, cheminformatics, molecular modeling), flow cytometry, mass spectrometry, high throughput screening (biochemical, cell-based, label-free assays), nuclear magnetic resonance, and X-ray crystallography.
  • End Users: Academic institutions, biotechnology companies, contract research organizations, and pharmaceutical companies.
  • Therapeutic Areas: Oncology, cardiovascular disorders, central nervous system disorders, metabolic disorders, and infectious diseases.
  • Molecule Types: Small molecules, peptides, oligonucleotides, and biologics.
  • Business Models: Fee-for-service contracts, partnership licensing, and collaborative research initiatives.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, UAE, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, and key Southeast Asian countries).

Leading industry participants include Charles River Laboratories International, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Evotec SE, IQVIA Holdings, Eurofins Scientific, Syngene International, and Sai Life Sciences.

Key Takeaways for Senior Decision-Makers

  • Emerging automation, artificial intelligence, and omics technologies are transforming traditional discovery methods, enabling higher throughput and improved predictive modeling for both small and large molecule drug candidates.
  • Integrated approaches, combining computational and wet-lab expertise, are fueling collaborative models that bring together academic, biotech, and CRO resources for greater speed and translational impact.
  • Service providers are developing specialized centers of excellence and modular technology platforms, allowing for regional resilience and operational agility amid supply chain or regulatory changes.
  • Diversification of business models, including outcome-based packages and flexible partnerships, align investments with sponsor risk profiles and promote more efficient project execution.
  • As therapeutic area demand shifts toward precision medicine and novel modalities, companies increasingly require tailored compound libraries and advanced analytical platforms to remain competitive.

Tariff Impact on the Drug Discovery Services Market

Revised U.S. tariff schedules in 2025 are driving adjustments in procurement, outsourcing, and global supply chain strategies. Upstream cost increases for critical reagents and instrumentation have prompted a move toward near-sourcing and flexible manufacturing footprints. This shift allows service providers to minimize exposure to volatile trade policy while maintaining workflow continuity and compliance.

Providers are also consolidating high-value activities, such as in vitro toxicology and advanced bioanalytical testing, into centralized centers to control cost and enhance quality oversight. Deploying analytical platforms and screening libraries locally reduces dependency on cross-border logistics and increases resilience.

Methodology & Data Sources

Our research process integrates secondary analysis, expert interviews, and data triangulation. We reviewed scientific literature, patent databases, company reports, and regulatory filings, supplemented by perspectives from industry experts and R&D leaders. Quantitative data was drawn from proprietary industry sources and benchmarked against validated market indicators to ensure reliable, actionable insights.

Why This Report Matters

  • Enables strategic decision-making for biopharma executives by illustrating key technology adoption trends and partnership opportunities.
  • Supports investment planners, portfolio managers, and business development leaders in navigating shifting commercial models and regional dynamics.
  • Equips procurement and operations stakeholders to benchmark costs, assess provider capabilities, and future-proof supply chain strategies in a fast-changing environment.

Conclusion

The drug discovery services market offers expanding opportunities for organizations ready to leverage innovation, integrated business models, and strategic alliances. In-depth analysis of technology, partnership, and regional trends empowers executives to align investments and lead in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Discovery Services Market, by Service Type
8.1. Introduction
8.2. Adme Dmpk Testing
8.2.1. Bioanalytical Services
8.2.2. in Vitro Adme
8.2.3. in Vivo Pharmacokinetics
8.3. Biomarker Discovery
8.3.1. Genomic Biomarkers
8.3.2. Metabolomic Biomarkers
8.3.3. Proteomic Biomarkers
8.4. Compound Synthesis & Scale Up
8.4.1. Custom Synthesis
8.4.2. Gmp Manufacturing
8.4.3. Process Development
8.5. Hit Screening
8.5.1. Fragment Screening
8.5.2. High Content Screening
8.5.3. High Throughput Screening
8.5.4. Virtual Screening
8.6. Lead Optimization
8.6.1. Admet Prediction
8.6.2. Computational Chemistry
8.6.3. Medicinal Chemistry
8.6.4. Structure Based Design
8.7. Target Identification
8.7.1. Bioinformatics
8.7.2. Genomics
8.7.3. High Content Screening
8.7.4. Proteomics
8.8. Toxicity Testing
8.8.1. in Vitro Toxicology
8.8.2. in Vivo Toxicology
8.8.3. Safety Pharmacology
9. Drug Discovery Services Market, by Technology
9.1. Introduction
9.2. Computational Biology
9.2.1. Bioinformatics
9.2.2. Cheminformatics
9.2.3. Molecular Modeling
9.3. Flow Cytometry
9.4. High Throughput Screening
9.4.1. Biochemical Assays
9.4.2. Cell Based Assays
9.4.3. Label Free Assays
9.5. Mass Spectrometry
9.6. Nuclear Magnetic Resonance
9.7. X Ray Crystallography
10. Drug Discovery Services Market, by End User
10.1. Introduction
10.2. Academic Institutions
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
11. Drug Discovery Services Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular Disorders
11.3. Central Nervous System Disorders
11.4. Infectious Diseases
11.5. Metabolic Disorders
11.6. Oncology
12. Drug Discovery Services Market, by Molecule Type
12.1. Introduction
12.2. Biologics
12.3. Oligonucleotides
12.4. Peptides
12.5. Small Molecules
13. Drug Discovery Services Market, by Business Model
13.1. Introduction
13.2. Collaborative Research
13.3. Fee For Service
13.4. Partnership Licensing
14. Americas Drug Discovery Services Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Drug Discovery Services Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Drug Discovery Services Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Charles River Laboratories International, Inc.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Laboratory Corporation of America Holdings
17.3.4. Evotec SE
17.3.5. IQVIA Holdings Inc.
17.3.6. Eurofins Scientific SE
17.3.7. Syngene International Ltd.
17.3.8. Sai Life Sciences Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DRUG DISCOVERY SERVICES MARKET MULTI-CURRENCY
FIGURE 2. DRUG DISCOVERY SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO ADME, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO PHARMACOKINETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMIC BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMIC BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GMP MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FRAGMENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LABEL FREE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COLLABORATIVE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FEE FOR SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PARTNERSHIP LICENSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 112. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 114. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 115. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 116. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 117. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 118. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 119. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 120. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 122. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 123. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 125. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 127. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 129. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 131. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 132. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 133. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 134. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 203. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 205. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 207. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 208. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 209. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 211. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 213. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 214. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 216. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 218. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 219. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 220. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 221. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 222. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 223. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 224. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 225. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 226. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 228. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 229. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 231. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 248. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 249. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 250. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 251. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 252. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 253. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 254. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 256. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 258. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 259. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 261. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 262. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 263. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 265. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 266. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 267. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 268. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 269. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 270. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 271. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 273. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 274. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 276. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 277. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Discovery Services market report include:
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • Evotec SE
  • IQVIA Holdings Inc.
  • Eurofins Scientific SE
  • Syngene International Ltd.
  • Sai Life Sciences Limited

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 28.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 55.84 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030 - Product Image

Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030

  • Report
  • 451 Pages
  • Global
From
Drug Discovery Services - Global Strategic Business Report - Product Image

Drug Discovery Services - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Drug Discovery Services Market Report 2025 - Product Image

Drug Discovery Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drug Discovery Services Market Opportunities and Strategies to 2033 - Product Image

Drug Discovery Services Market Opportunities and Strategies to 2033

  • Report
  • 323 Pages
  • Global
From
2025 Global Forecast for Drug Discovery Services Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Drug Discovery Services Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.